journal article·2021-03-03

Programmable Repurposing of Existing Drugs as Pharmaceutical Elements for the Construction of Aptamer–Drug Conjugates

Fei Gao, Jinming Zhou, Yang Sun, Cai Yang, Shiyan Zhang, Ruowen Wang, Weihong Tan

Publisher page

Abstract

Converting marketed drug molecules into phosphoramidites may present a potential strategy to facilitate the development of aptamer-drug conjugates (ApDCs) by a DNA synthesizer in a programmable way; however, quite limited methods were reported. Herein, we demonstrated a general approach by repurposing camptothecin (CPT) species. Commonly used inactive ingredients in pharmaceuticals are investigated and selected as a bonding moiety, from which 2-mercaptoethoxy ethanol and thioglycerol were efficiently incorporated with CPT to give the precursors. Cell viability and molecular docking results of the precursors supported that incorporation of the bonding moiety would not interrupt the inhibitory activity. Therefore, corresponding phosphoramidites were prepared as pharmaceutical elements, and a series of ApDCs were constructed automatically by solid-phase synthesis. Biological studies revealed that CPT elements could be specifically delivered to HCT116 cells by an aptamer and released inside cells. This kind of programmable repurposing may take advantage of established safety data and efficacy of existing drugs resulting in a faster development of ApDCs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · DNA and Nucleic Acid Chemistry · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Molecular Medicine (IMM), State Key Laboratory of Oncogenes and Related Genes, Renji Hospital, Shanghai Jiao Tong University School of Medicine, and College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai 200240, China

Institute of Translation Medicine, Shanghai University, Shanghai 200444, China

Key Laboratory of the Ministry of Education for Advanced Catalysis Materials, Department of Chemistry, Zhejiang Normal University, 688 Yingbin Road, Jinhua 321004, China

The Cancer Hospital of the University of Chinese Academy of Sciences, Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, China

Funding

National Natural Science Foundation of China · Innovative Research Team of High Level Local Universities in Shanghai

References (44)

Show source-provided references
1. 10.1038/534314a10.1038/534314a ↗
2. 10.1038/nbt.278610.1038/nbt.2786 ↗
3. 10.1038/s41573-019-0050-310.1038/s41573-019-0050-3 ↗
4. 10.1038/nrd.2017.23210.1038/nrd.2017.232 ↗
5. 10.1021/acsami.9b2131110.1021/acsami.9b21311 ↗
6. 10.1021/acsami.8b1636310.1021/acsami.8b16363 ↗
7. 10.1002/anie.20190349810.1002/anie.201903498 ↗
8. 10.1002/med.2153310.1002/med.21533 ↗
9. 10.1021/acs.chemrev.8b0000610.1021/acs.chemrev.8b00006 ↗
10. 10.1021/acsami.8b1172310.1021/acsami.8b11723 ↗
11. 10.1021/acsami.7b0228110.1021/acsami.7b02281 ↗
12. 10.1016/j.addr.2016.06.01510.1016/j.addr.2016.06.015 ↗
13. 10.1016/j.chempr.2019.03.02310.1016/j.chempr.2019.03.023 ↗
14. 10.1021/jacs.5b0790810.1021/jacs.5b07908 ↗
15. 10.1021/jacs.7b0286510.1021/jacs.7b02865 ↗
16. 10.1021/ja411739510.1021/ja4117395 ↗
17. 10.1021/ja00428a04510.1021/ja00428a045 ↗
18. 10.1021/acsami.0c0575010.1021/acsami.0c05750 ↗
19. 10.1016/j.addr.2018.08.00510.1016/j.addr.2018.08.005 ↗
20. 10.1038/nrd.2016.19910.1038/nrd.2016.199 ↗
21. 10.1073/pnas.060261510310.1073/pnas.0602615103 ↗
22. 10.7150/thno.3188510.7150/thno.31885 ↗
23. 10.1021/cr300468w10.1021/cr300468w ↗
24. 10.1021/jacs.9b1051010.1021/jacs.9b10510 ↗
25. 10.1021/acsami.0c0735310.1021/acsami.0c07353 ↗
26. 10.1016/j.jconrel.2017.02.02610.1016/j.jconrel.2017.02.026 ↗
27. 10.1517/17425247.3.3.31110.1517/17425247.3.3.311 ↗
28. 10.1038/s41467-017-01565-610.1038/s41467-017-01565-6 ↗
29. 10.1002/cbic.20080080510.1002/cbic.200800805 ↗
30. 10.1021/ja00968a05710.1021/ja00968a057 ↗
31. 10.1038/nprot.2008.17410.1038/nprot.2008.174 ↗
32. 10.1021/jm00105a01710.1021/jm00105a017 ↗
33. Eng W. K. · Mol. Pharmacol. · 1988 · 34 · 755
34. 10.1016/j.bmcl.2016.12.08510.1016/j.bmcl.2016.12.085 ↗
35. 10.1038/bjc.1997.49110.1038/bjc.1997.491 ↗
36. 10.1021/cr078021010.1021/cr0780210 ↗
37. 10.1023/A:101891922445010.1023/A:1018919224450 ↗
38. 10.1021/mp900243b10.1021/mp900243b ↗
39. 10.1002/anie.20090392410.1002/anie.200903924 ↗
40. 10.1016/j.jmb.2004.03.07710.1016/j.jmb.2004.03.077 ↗
41. 10.1039/C4SC01162G10.1039/C4SC01162G ↗
42. 10.1002/anie.20190380710.1002/anie.201903807 ↗
43. 10.1016/j.biomaterials.2018.08.02110.1016/j.biomaterials.2018.08.021 ↗
44. 10.1002/anie.20140577810.1002/anie.201405778 ↗